WARNING
Nephrotoxicity: Bacitracin in parenteral (intramuscular) therapy may cause renal failure due to tubular and glomerular necrosis. Its use should be restricted to infants with staphylococcal pneumonia and empyema when due to organisms shown to be susceptible to bacitracin. It should be used only where adequate laboratory facilities are available and when constant supervision of the patient is possible.
Renal function should be carefully determined prior to and daily during therapy. The recommended daily dose should not be exceeded and fluid intake and urinary output should be maintained at proper levels to avoid kidney toxicity. If renal toxicity occurs the drug should be discontinued. The concurrent use of other nephrotoxic drugs, particularly streptomycin, kanamycin, polymyxin B, polymyxin E (colistin), neomycin, and vancomycin, should be avoided.
|
BACIIM SUMMARY
The vial content of Bacitracin for Injection USP is sterile. The therapeutic class of the drug is antibacterial and is intended for intramuscular use.
BACiiM (Bacitracin) is indicated for the following:
In accord with the statements in the “ Warning Box ” the use of intramuscular bacitracin is limited to the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of bacitracin and other antibacterial drugs, bacitracin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
|
NEWS HIGHLIGHTSMedia Articles Related to Baciim (Bacitracin)
Rescue Combination for MRSA Pneumonia With Pneumothorax Source: Medscape Critical Care Headlines [2017.09.27] The authors describe a combination therapy for the successful treatment of a case of severe community-acquired MRSA pneumonia complicated by pneumothorax. BMC Pulmonary Medicine
Do I Have Pneumonia? Symptoms & Signs Source: MedicineNet Chronic Cough Specialty [2017.09.19] Title: Do I Have Pneumonia? Symptoms & Signs Category: MedicineNet Quiz Created: 12/2/2010 12:00:00 AM Last Editorial Review: 9/19/2017 5:57:22 PM
Is Pneumonia Contagious? Source: MedicineNet Pneumococcal Vaccination Specialty [2017.06.27] Title: Is Pneumonia Contagious? Category: Diseases and Conditions Created: 4/7/2015 12:00:00 AM Last Editorial Review: 6/27/2017 12:00:00 AM
Pneumonia Source: MedicineNet Adenoids and Tonsils Specialty [2017.04.25] Title: Pneumonia Category: Diseases and Conditions Created: 12/31/1997 12:00:00 AM Last Editorial Review: 4/25/2017 12:00:00 AM
Antibiotics in Comatose Mechanically Ventilated Patients Source: Medscape Critical Care Headlines [2017.09.27] How are pneumonia and pneumonitis differentiated among comatose ICU patients receiving mechanical ventilation -- and what is the appropriate antibiotic strategy? Critical Care Medicine
Published Studies Related to Baciim (Bacitracin)
Effects of feeding diets containing bacitracin methylene disalicylate to heat-stressed finishing pigs. [2011.06] The objective of this study was to evaluate the effects of heat stress and dietary bacitracin methylene disalicylate (BMD) on growth performance, carcass characteristics, and immunological responses in finishing pigs. Four groups of 32 finishing pigs (n = 128) with initial BW between 80 to 90 kg were used...
Effects of dietary mannan oligosaccharide, bacitracin methylene disalicylate, or both on the live performance and intestinal microbiology of turkeys. [2004.07] Hybrid male turkeys were fed to 18 wk of age in a completely randomized design with 10 replicate pens (18 birds each) per treatment to compare growth promoters. Four dietary treatments were used: negative control (CON), bacitracin methylene disalicyate (BMD) at 55 mg/kg to 6 wk and 27.5 mg/kg thereafter, mannan oligosaccharide (MOS) at 0.1% to 6 wk and 0.05% thereafter, and BMD and MOS at concentrations listed above...
The efficacy of bacitracin methylene disalicylate when fed in combination with narasin in the management of necrotic enteritis in broiler chickens. [2003.03] The efficacy of bacitracin methylene disalicylate (BMD) in the management of necrotic enteritis (NE) when fed in combination with narasin was investigated in a floor-pen study of 2,000 broiler chickens using a Clostridium perfringens inoculum challenge model.
Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. [2001.08.15] Patients who are colonized with enteric vancomycin-resistant Enterococcus faecium (VREF) are a major reservoir for transmission of and infection with this organism. In a randomized, controlled study to assess the effectiveness of high-dose bacitracin in the eradication of enteric VREF, 12 patients who were colonized with VREF were randomized to receive placebo (n=6) or orally administered zinc bacitracin (n=6) for 10 days...
Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization. [1999.05] We performed a randomized prospective study of 5-day treatment with topical mupirocin or bacitracin for the elimination of Staphylococcus aureus nasal colonization in healthcare workers (HCWs). Nasal cultures were obtained from 141 HCWs, 37 (26%) of whom showed S...
Clinical Trials Related to Baciim (Bacitracin)
Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients [Not yet recruiting]
This study will investigate how the use of Tranexamic acid and Bacitracin applied to the
bleeding site after the hemodialysis fistula needle is removed will affect skin wound
healing.
Clinical Evaluation of Bacitracin [Completed]
Using Santyl or Bacitracin on Second Degree Burns [Withdrawn]
Subjects who have minor, second degree burns may be enrolled in this study. Subjects will
receive either Santyl ointment or bacitracin ointment to apply to the burn until it heals.
Bandages will be used to keep the burn covered while it heals. Second degree burns
generally leave a scar. Once the burn heals, lotion and an appropriate bandage will be used
to try to minimize the appearance of a scar.
The study hypothesis is that burns treated with Santyl will have a better scar appearance
than burns treated with bacitracin.
Subjects enrolled in this study will make once a week visits to the University of Kansas
Medical Center outpatient burn clinic until the burn heals. The burn will be assessed for
healing at these visits. Once healed, visits to the clinic will be every 1-3 months for up
to 1 year. At these visits, the appearance of the scar will be evaluated
The Relationship of Hemoglobin A1c and Diabetic Wound Healing [Terminated]
The purpose of this study is to investigate the relationship of hemoglobin A1c in diabetic
wound healing. Additionally, a comparison of two wound dressings, AmeriGel® (Amerx Health
Care Corp., Clearwater, FL) and Bacitracin, with and without vitamin C supplementation, will
be done to evaluate impact on time to wound closure.
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge [Completed]
This study will evaluate the efficacy of a nasopore sponge dressing soaked in Bacitracin VS
a sponge soaked in Saline / and the administration of oral antibiotics.
|